Monika Kaushik

Monika Kaushik

Auto-generated profile, based on publicly available information

Monika Kaushik

School of medical and allied sciences, K R Mangalam University, Sohna Road, Gurugram 122103, Haryana, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AAAnkit Awasthi
Ankit Awasthi
DGDr. Monica Gulati
Dr. Monica Gulati
BKBIMLESH KUMAR
BIMLESH KUMAR
JKJaskiran Kaur
Jaskiran Kaur
SVSukriti Vishwas
Sukriti Vishwas
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
Diabetic wound (DW) is a secondary application of uncontrolled diabetes and affects about 42.2% of diabetics. If the disease is left untreated/uncontrolled, then it may further lead to amputation of organs. In recent years, huge research has been done in the area of wound dressing to have a better maintenance of DW. These include gauze, films, foams or, hydrocolloid‐based dressings as well as polysaccharide‐ and polymer‐based dressings. In recent years, scaffolds have played major role as biomaterial for wound dressing due to its tissue regeneration properties as well as fluid absorption capacity. These are three‐dimensional polymeric structures formed from polymers that help in tissue rejuvenation. These offer a large surface area to volume ratio to allow cell adhesion and exudate absorbing capacity and antibacterial properties. They also offer a better retention as well as sustained release of drugs that are directly impregnated to the scaffolds or the ones that are loaded in nanocarriers that are impregnated onto scaffolds. The present review comprehensively describes the pathogenesis of DW, various dressings that are used so far for DW, the limitation of currently used wound dressings, role of scaffolds in topical delivery of drugs, materials used for scaffold fabrication, and application of various polymer‐based scaffolds for treating DW.

8 December 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TTTahreen Taj
Tahreen Taj
MKMonika Kaushik
Monika Kaushik
AIAnas Islam
Anas Islam
Joy DasJoy Das
Joy Das
BKBIMLESH KUMAR
BIMLESH KUMAR
Mohammad Yousuf AnsariMohammad Yousuf Ansari
Mohammad Yousuf Ansari
The microbiota-brain interaction is a complex network connecting gut microbiota to the enteric nervous system (ENS) and the central nervous system (CNS) that are crucial for neurotransmission and neurological health. Metabolites such as short-chain fatty acids (SCFA), neurotransmitters, and neuromodulators from the gut microbiota influence behavior and brain function. This review focuses on the study related with gut bacteria, including Bifidobacterium infantis and Lactobacillus species, producing various metabolites in gut including bile acids, SCFA, histamine, and others to communicate with the brain or CNS. Dysbiosis can lead to neurological conditions such as anxiety, depression, PD, and AD. SCFAs from gut bacteria bind to the free fatty acid receptors of intestinal epithelial cells (IECs), affecting neurones and influencing neuroactivity. Gut bacteria also produce neurotransmitters that regulate growth hormone release through interactions with the CNS and endocrine systems. Brain signals interact directly with the pituitary and adrenal glands through the hypothalamic-pituitary-adrenal (HPA) axis, which in turn communicates with enteroendocrine cells (EECs). Investigating probiotics, prebiotics, and dietary changes could open new avenues for treatment for mental and neurological problems.

18 February 2025 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NMNaheed Mojgani
Naheed Mojgani
SASumel Ashique
Sumel Ashique
Mehran MoradiMehran Moradi
Mehran Moradi
MBMasoumeh Bagheri
Masoumeh Bagheri
AGAshish Garg
Ashish Garg
Mohammad Yousuf AnsariMohammad Yousuf Ansari
Mohammad Yousuf Ansari

29 May 2022 in South African Journal of Botany
Verified
Journal Article
Open access
AAAnkit Awasthi
Ankit Awasthi
AKAnkit Kumar
Ankit Kumar
RKRajan Kumar
Rajan Kumar
SVSukriti Vishwas
Sukriti Vishwas
RKRubiya Khursheed
Rubiya Khursheed
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH

20 May 2026 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
MKMonika Kaushik
Monika Kaushik
MVMurugesan Vanangamudi
Murugesan Vanangamudi
SSSumit Sharma
Sumit Sharma
PGPrathap Madeswara Guptha
Prathap Madeswara Guptha
VSVijayaraj Surendran
Vijayaraj Surendran
Sachchida Nand RaiSachchida Nand Rai
Sachchida Nand Rai

15 May 2026 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
MKMonika Kaushik
Monika Kaushik
MPMrugendra Potdar
Mrugendra Potdar
PMPrathap Madeswaraguptha
Prathap Madeswaraguptha
MVMurugesan Vanangamudi
Murugesan Vanangamudi
MAMd Abubakar
Md Abubakar
Sachchida Nand RaiSachchida Nand Rai
Sachchida Nand Rai
Introduction: Mitochondria play an important role in maintaining redox balance, energy, calcium, and the viability of neurons. The mitochondrial dysfunction is one of the primary sources of glial activation and dopaminergic neuron loss in Parkinson's disease (PD). The key biochemical elements of the pathogenesis of PD include impaired oxidative phosphorylation, elevated generation of reactive oxygen species (ROS), and impaired mitophagy. Methods: This review is a synthesis and stringent evaluation of recent experimental, clinical and genetic studies relating mitochondrial dysfunction and Parkinson's disease (PD). We examined information on bioenergetics, mitochondrial dynamics, calcium homeostasis, and interactions between neurons and glia. The molecular and therapeutic importance of therapies, such as mitophagy modulators, bioenergetic enhancers, and mitochondrial antioxidants, was investigated. The absence of Complex I, excess ROS, mitochondrial DNA damage, and nonfunctioning fusionfission cycles leads to neurodegeneration. The glial metabolic abnormalities worsen the oxidative stress and neuroinflammation, weakening the support of the neurons. The effects of impaired mitophagy are the accumulation of dysfunctional mitochondria, and the effects of calcium overload disrupt energy metabolism. Neuroprotective effects of such substances as spermidine, urolithin A, resveratrol, αlipoic acid, MitoQ, SkQ1, or CoQ10 have been shown using preclinical research. Sacrifices such as exercising and proper dieting enable the mitochondria to perform better and become stronger. Discussion: Mitochondrial dysfunction enhances the progression of PD through oxidative stress, bioenergetic breakdown, and inflammatory signalling. Attention to these related systems is an entire way to alter the direction of a disease. Conclusion: PD can be treated using an increase in mitochondrial quality control, redox regulation, and metabolic efficiency. Continued studies in the framework of precision medicine are required to validate the safety and effectiveness of mitochondrial-targeted medications.